ONCAlert | 2017 NANETS Symposium

Toxicities Associated with PARP Inhibitors in Ovarian Cancer

Ursula A. Matulonis, MD
Published Online:11:31 AM, Wed August 2, 2017

Ursula A. Matulonis, MD, professor of Medicine, Harvard Medical School, medical director of Gynecologic Oncology, Dana-Farber Cancer Institute, discusses the toxicities that are associated with PARP inhibitors in ovarian cancer.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.